![Peter Llewellyn-Davies](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Peter Llewellyn-Davies
Director/Board Member at
SHIELD THERAPEUTICS PLC
Net worth: 14 263 $ as of 31/05/2026
Profile
Peter Llewellyn-Davies is the founder of InvIOs GmbH, founded in 2022, where the titles held are Chief Executive Officer & Chief Financial Officer.
Mr. Llewellyn-Davies is also the founder of Acceleration Partners LLC..
Current jobs include Chief Executive Officer at invIOs Holding AG since 2021, Chairman-Management Board at Biotechnologie-Industrie-Organisation Austria since 2020, and Independent Non-Executive Director at Shield Therapeutics Plc since 2016.
Former jobs include Executive Director-Finance at Süd-Chemie AG, Managing Director at Müller Dairy (UK) Ltd., Director at Catherex, Inc., Chief Financial Officer & Executive Director at Wilex, Inc., Non-Executive Director at Immunocore Holdings Plc, Member-Supervisory Board at 2invest AG from 2017 to 2021, Chief Financial Officer at CoreOptics GmbH, Chief Financial & Business Officer at MediGene AG from 2012 to 2016, Chief Financial Officer at Heidelberg Pharma AG from 2010 to 2012, and Chief Financial & Business Officer at APEIRON Biologics GmbH from 2017 to 2018.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 31/12/2025 | 177,842 ( 0.02% ) | 14 263 $ | 31/05/2026 |
Peter Llewellyn-Davies active positions
| Companies | Position | Start |
|---|---|---|
| SHIELD THERAPEUTICS PLC | Director/Board Member | 01/02/2016 |
invIOs Holding AG | Chief Executive Officer | 01/12/2021 |
Biotechnologie-Industrie-Organisation Austria | Chief Executive Officer | 01/12/2020 |
Former positions of Peter Llewellyn-Davies
| Companies | Position | End |
|---|---|---|
| 2INVEST AG | Director/Board Member | 28/01/2021 |
| MEDIGENE AG | Director of Finance/CFO | 31/03/2016 |
| HEIDELBERG PHARMA AG | Director of Finance/CFO | 10/10/2012 |
APEIRON Biologics AG
 APEIRON Biologics AG BiotechnologyHealth Technology Develops therapies for cancer immunotherapy and respiratory diseases | Chief Executive Officer | - |
Acceleration Partners LLC
 Acceleration Partners LLC Advertising/Marketing ServicesCommercial Services Operates as a marketing agency | Founder | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
42
1st degree connections
14
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 14 |
|---|---|
2invest AG
 2invest AG Financial ConglomeratesFinance Operates as an investment holding company primarily investing in biotechnology | Finance |
CoreOptics GmbH
 CoreOptics GmbH Electronic Production EquipmentElectronic Technology Develops and manufactures subsystems for optical networking applications | Electronic Technology |
Süd-Chemie AG
 Süd-Chemie AG Chemicals: SpecialtyProcess Industries Manufactures inorganic chemical produtcs | Process Industries |
MediGene AG
 MediGene AG BiotechnologyHealth Technology Engages in the clinical research and development of novel drugs against cancer & autoimmune diseases with focus on personalized immunotherapies | Health Technology |
Heidelberg Pharma AG
 Heidelberg Pharma AG Pharmaceuticals: MajorHealth Technology Develops cancer therapies | Health Technology |
Müller Dairy (UK) Ltd.
 Müller Dairy (UK) Ltd. Food: Meat/Fish/DairyConsumer Non-Durables Manufactures and distributes dairy products | Consumer Non-Durables |
APEIRON Biologics AG
APEIRON Biologics AG BiotechnologyHealth Technology Develops therapies for cancer immunotherapy and respiratory diseases | Health Technology |
Catherex, Inc.
 Catherex, Inc. Miscellaneous Commercial ServicesCommercial Services Provides medical research services | Commercial Services |
Wilex, Inc.
 Wilex, Inc. Medical/Nursing ServicesHealth Services Develops medical diagnostic tests | Health Services |
Acceleration Partners LLC
Acceleration Partners LLC Advertising/Marketing ServicesCommercial Services Operates as a marketing agency | Commercial Services |
Shield Therapeutics Plc
 Shield Therapeutics Plc Pharmaceuticals: MajorHealth Technology Develops and commercializes late stage pharmaceutical products | Health Technology |
Immunocore Holdings Plc
 Immunocore Holdings Plc BiotechnologyHealth Technology Operates as a biotechnology company which develops immunotherapies | Health Technology |
invIOs Holding AG | |
Biotechnologie-Industrie-Organisation Austria |
- Stock Market
- Insiders
- Peter Llewellyn-Davies
